Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma

American Journal of Clinical Dermatology(2024)10.1007/s40257-024-00852-5Source: DataRank Database

Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma is a research paper published in American Journal of Clinical Dermatology (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.42)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Jason J. Luke ORCID,Ryan C. Augustin ORCID

Live enrichment

PubMed:38409643 PMC:PMC11552441 OpenAlex:https://openalex.org/W4392153612

National Cancer Institute

Grant: UM1CA186690

National Cancer Institute

Grant: P50CA254865

National Cancer Institute

Grant: P30CA047904

National Institutes of Health

Grant: 5P50CA254865-02

Melanoma and Skin Cancer Program SPORE

National Institutes of Health

Grant: 5UM1CA186690-09

NCI ETCTN Pittsburgh Cancer Consortium (PCC)

National Institutes of Health

Grant: 3P30CA047904-07S1

CANCER CENTER SUPPORT GRANT

FWCI

1.42

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11552441/pdf/nihms-2032314.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40257-024-00852-5.pdf

publisherhttps://link.springer.com/article/10.1007/s40257-024-00852-5/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11552441

Fields of Study

Cutaneous Melanoma Detection and ManagementMelanoma and MAPK PathwaysCAR-T cell therapy research03 medical and health sciences0302 clinical medicineHumansMelanomaSkin NeoplasmsImmune Checkpoint InhibitorsBiomarkers, TumorNeoadjuvant TherapyProto-Oncogene Proteins B-rafNeoplasm StagingNeoplasm Recurrence, Local

MeSH Terms

Immune Checkpoint InhibitorsHumansMelanomaNeoplasm Recurrence, LocalNeoplasm StagingSkin NeoplasmsBiomarkers, TumorNeoadjuvant TherapyProto-Oncogene Proteins B-raf

Keywords

MedicineSystemic therapyPharmacotherapyMelanomaIntensive care medicineDermatologyInternal medicineCancerProto-Oncogene Proteins B-rafSkin NeoplasmsBiomarkers, TumorHumansNeoplasm Recurrence, LocalImmune Checkpoint InhibitorsNeoadjuvant TherapyNeoplasm Staging

Sustainable Development Goals

SDG 0: Good health and well-being

Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma

FAIR Checklist

Authors (2)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)